A
Accellacare | McFarland Clinic, Ames, IA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
PF-07321332
Ritonavir
BOTOX
Ubrogepant
BHV-7000
Parent organization
This site is a part of Accellacare
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 6 total trials
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
Enrolling
Focal Epilepsy
Drug: BHV-7000
Drug: Placebo
Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea...
Invitation-only
Migraine
Drug: Ubrogepant
Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea...
Enrolling
Migraine
Drug: Placebo-Matching Ubrogepant
Drug: Ubrogepant
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems